Can Tirzepatide Cause Yeast Infections?

Why some people raise this question, and how to think it through

It's a question our prescribers hear most weeks, usually from people who've started tirzepatide and noticed a vaginal or oral yeast infection for the first time in a while, or from people who've read something online and want to know whether to worry before they begin. The honest answer is: the medicine itself isn't listed as a direct cause, but the context in which people take it can shift things.

Tirzepatide works as a dual GIP and GLP-1 receptor agonist, reducing appetite and slowing gastric emptying, and it has a meaningful effect on blood glucose levels. That glucose effect is actually part of its therapeutic value, particularly in people living with type 2 diabetes. But during the early titration period, blood-sugar levels can fluctuate. Higher glucose in the body and in mucosal secretions creates a more hospitable environment for Candida, the fungus responsible for most common yeast infections. So while tirzepatide doesn't trigger yeast growth directly, the glycaemic changes it produces (especially early on) can play a supporting role in susceptible individuals.

If you already have diabetes or prediabetes, it's worth knowing your baseline risk of fungal infections is higher regardless of treatment. The NHS patient information for tirzepatide gives a clear overview of what the medicine does and what to watch for during treatment.

What the SmPC says, and what falls outside it

The Summary of Product Characteristics for tirzepatide, which sets out the medicine's licensed safety profile, does not list yeast infections among recognised adverse reactions. That matters. It means the clinical trial programme (involving thousands of participants across the SURMOUNT trials) did not produce a signal strong enough to establish a formal causal link.

That doesn't mean individual cases don't happen. Post-marketing surveillance and real-world use often surface patterns that trials aren't powered to detect at low frequency, particularly for conditions like yeast infections that people may not always report to a study team. Readers who want to see the full adverse-reaction data can review the Mounjaro SmPC on the eMC, which is the authoritative reference for licensed prescribing information in the UK.

What this means practically: if you develop a yeast infection while taking tirzepatide, the medicine is not automatically the cause. Other factors (antibiotic use, a weakened immune response, hormonal changes, or pre-existing diabetes) are at least as likely to be responsible. The timing of a new symptom doesn't always equal causation.

For a broader look at how tirzepatide affects the body and what to expect during treatment, the tirzepatide overview on our site covers the clinical picture in detail.

What to do if you think there's a connection

A single episode of thrush during any new treatment is common and usually straightforward to treat with over-the-counter options. It doesn't mean you need to stop tirzepatide, and it doesn't mean the medicine is wrong for you. But there are situations where it warrants a proper clinical conversation rather than self-management.

If you've had two or more infections within a few months, if symptoms are severe or don't resolve with standard treatment, or if you have undiagnosed or poorly controlled diabetes, speak to your GP or prescriber. Recurrent fungal infections can sometimes be a signal that blood glucose isn't as well managed as it appears, which is itself something your prescribing team would want to know about.

People who are interested in the broader picture of how tirzepatide is associated with urinary and bladder symptoms may find the page on whether Mounjaro can cause urine infections a useful companion read, as it covers overlapping territory with a different lens, and there are also dedicated pages exploring whether Mounjaro can cause water infections and whether Mounjaro can cause bladder infections for readers who want to go deeper on those specific questions. There's also a dedicated look at Mounjaro and yeast infections specifically for readers who've been prescribed that branded form.

Tirzepatide is a prescription-only medicine, which means every person taking it through nume... (through our service) has a named prescriber available for exactly these conversations. Side effects, new symptoms, and changes to your health during treatment are all things our clinical team expects to hear about. You can explore what to expect from a weight-loss treatment consultation on the weight-loss treatments overview.

For those thinking about the cost of treatment alongside these clinical questions, the Mounjaro price comparison page sets out what the UK private market looks like and what a legitimate service includes. Separately, anyone wanting to report a side effect to the UK regulator directly can do so through the MHRA Yellow Card scheme, it takes a few minutes and genuinely informs ongoing safety monitoring.